| Mr Brad M Sewall, MS LCMHC RN | |
|
49 School Street, Hartford, VT 05047 | |
| (802) 295-3031 | |
| (802) 295-0820 |
| Full Name | Mr Brad M Sewall |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 49 School Street, Hartford, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215002522 | NPI | - | NPPES |
| Entity Name | Health Care And Rehabilitation Services Of Southeastern Vermont Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790861342 PECOS PAC ID: 4183698830 Enrollment ID: O20040819001433 |
News Archive
Aspirin has long been hailed as one of the most effective, low-cost ways to help guard against a heart attack or stroke. However, international medical researchers caution that low doses of aspirin also increase a patient's chance of developing an ulcer, often without warning signs.
GrowBLOX Sciences, Inc. a biotechnology and research company, announced today that The Company has relocated its corporate headquarters to Las Vegas, Nevada and has centralized its CFO and team in the heart of Clark County in anticipation of its Nevada project.
TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, announces the shipment of the first new 3M(TM) Optreoz(TM) 125-Z sterilizer with TSO3 STERIZONE(R) Technology.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE (bortezomib) for Injection, which updates the label to include additional long-term overall survival (OS) data from the VISTA trial.
A local research study conducted by KK Women's and Children's Hospital and Duke-NUS Graduate Medical School has found that pregnant patients benefit most from gestational diabetes mellitus (GDM) screening as it allows for timely interventions and brings about health benefits that far outweigh the cost.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Brad M Sewall, MS LCMHC RN P.o. Box 709, Hartford, VT 05047-0709 Ph: (802) 295-3031 | Mr Brad M Sewall, MS LCMHC RN 49 School Street, Hartford, VT 05047 Ph: (802) 295-3031 |
News Archive
Aspirin has long been hailed as one of the most effective, low-cost ways to help guard against a heart attack or stroke. However, international medical researchers caution that low doses of aspirin also increase a patient's chance of developing an ulcer, often without warning signs.
GrowBLOX Sciences, Inc. a biotechnology and research company, announced today that The Company has relocated its corporate headquarters to Las Vegas, Nevada and has centralized its CFO and team in the heart of Clark County in anticipation of its Nevada project.
TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, announces the shipment of the first new 3M(TM) Optreoz(TM) 125-Z sterilizer with TSO3 STERIZONE(R) Technology.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE (bortezomib) for Injection, which updates the label to include additional long-term overall survival (OS) data from the VISTA trial.
A local research study conducted by KK Women's and Children's Hospital and Duke-NUS Graduate Medical School has found that pregnant patients benefit most from gestational diabetes mellitus (GDM) screening as it allows for timely interventions and brings about health benefits that far outweigh the cost.
› Verified 5 days ago